Welcome to our dedicated page for Medical Properties Trust SEC filings (Ticker: MPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Medical Properties Trust's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Medical Properties Trust's regulatory disclosures and financial reporting.
Medical Properties Trust Inc ownership disclosure: The Vanguard Group filed a Schedule 13G/A reporting 0 shares beneficially owned, representing 0% of Common Stock following an internal realignment.
The filing explains that certain Vanguard subsidiaries or business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538, and that Vanguard no longer is deemed to have beneficial ownership of securities held by those subsidiaries. The filing is signed by Ashley Grim, Head of Global Fund Administration.
Williams Rosa Handley reported acquisition or exercise transactions in this Form 4 filing.
MEDICAL PROPERTIES TRUST INC reported that SVP of Operations Rosa Handley Williams received two equity awards of common stock totaling 63,750 shares on March 18, 2026. After these grants, she holds 452,774 shares directly.
One award of 42,500 shares vests in equal installments at the beginning of each of 12 calendar quarters starting April 1, 2026. The other 21,250-share award is performance-based and will be earned only if specific debt reduction and cash revenue growth targets set by the compensation committee are met over the period from January 1, 2026 through December 31, 2028. The actual number of performance shares ultimately issued will depend on achievement of these thresholds, including the opportunity to earn up to one third of the award for 2026 performance.
Medical Properties Trust Inc reported that SVP and Senior Advisor to the CEO Larry H. Portal acquired a total of 112,500 shares of common stock as equity awards. One grant of 75,000 shares vests in equal installments at the beginning of each of 12 calendar quarters starting April 1, 2026. A second award of 37,500 shares is performance-based and will be earned over the period from January 1, 2026 through December 31, 2028 based on specific debt reduction and cash revenue growth thresholds set by the compensation committee, with the actual shares issued varying according to performance.
MEDICAL PROPERTIES TRUST INC senior vice president of finance and treasurer Charles R. Lambert reported stock-based compensation awards. He acquired 50,000 shares of common stock at no cost and then an additional 25,000 shares, bringing his direct holdings to 392,401 shares after the second grant.
The 50,000-share award vests in equal installments at the beginning of each of the 12 calendar quarters starting on April 1, 2026. The 25,000-share award is performance-based and will be earned over the period from January 1, 2026 through December 31, 2028, depending on specific thresholds for overall debt reduction and cash revenue growth set by the compensation committee, with up to one third tied to 2026 performance.
Hanna James Kevin reported acquisition or exercise transactions in this Form 4 filing.
Medical Properties Trust granted equity awards to Senior VP, Controller & CAO James Kevin Hanna. He received 75,000 shares of common stock as a time-based award and 37,500 performance-based shares tied to debt reduction and cash revenue growth from January 1, 2026 through December 31, 2028. Following these grants, he directly holds 546,794 shares of common stock. The time-based shares vest in equal installments at the beginning of each of 12 calendar quarters starting April 1, 2026, while the performance award will be earned only if specific performance thresholds are achieved.
Medical Properties Trust, Inc. reported sharply improved results for 2025, moving from a large prior-year loss to a much smaller one while stabilizing its hospital real estate portfolio. Net income for the fourth quarter was $17 million, or $0.03 per share, compared with a net loss of $413 million, or $(0.69) per share, a year earlier. For the full year, the company recorded a net loss of $277 million, or $(0.46) per share, versus a $2.4 billion loss, or $(4.02) per share, in 2024, reflecting far lower impairment charges.
Normalized funds from operations, a key REIT cash-flow metric, were $106.6 million, or $0.18 per share, for the fourth quarter, essentially flat with the prior year, and $346.3 million, or $0.58 per share, for 2025, down from $482.7 million, or $0.80 per share, in 2024. The company highlighted progress repositioning challenged tenants, including new long-term leases and asset sales, and reiterated a goal of driving pro forma annualized cash rent from its current portfolio to at least $1 billion by the end of 2026.
MPT ended 2025 with total assets of $15.0 billion and debt, net of issuance costs and discounts, of $9.7 billion, resulting in financial leverage of 59.0% and an adjusted net debt to annualized EBITDAre ratio of 8.5x. The portfolio comprised 384 properties and approximately 39,000 licensed beds across nine countries, with general acute care hospitals representing the majority of assets and revenue.